Search Results 2121-2130 of 21664 for platelets

1. A Study to Assess the Effectiveness and Safety of Irinotecan Liposome Injection, 5-fluorouracil/Leucovorin Plus Oxaliplatin in Patients Not Previously Treated for Metastatic Pancreatic Cancer, Compared to Nab-paclitaxel+Gemcitabine Treatment - Mayo Clinic

   Platelet count ≥100,000/^;; Haemoglobin (Hgb) ≥ 9 g/dL obtained ≤ 14 days prior to randomisation. Adequate hepatic function as evidenced by: Serum total ...

2. Vaccine Therapy in Treating Patients With Previously Treated Stage II-III HER2-Positive Breast Cancer - Mayo Clinic

   Platelet count ≥ 75,000/mm^3; Hemoglobin ≥ 9.0 g/dL; Creatinine ≤ 2 x upper limit of normal (ULN); Serum glutamic oxaloacetic transaminase (SGOT) (aspartate ...

3. A Study to Evaluate the Safety and Effectiveness of Beating Heart Mitral Valve Repair with the HARPOON™ System - Mayo Clinic

   acute anemia (Hb < 9 g/dL) or thrombocytopenia (platelets < 50,000 cells mcL). 22. Refuse blood products. 23. Planned treatment with any other ...

4. S0931, Everolimus in Treating Patients With Kidney Cancer Who Have Undergone Surgery - Mayo Clinic

   ANC ≥ 1,500/mm^3 Platelet count ≥ 100,000/mm^3; Serum creatinine ≤ 2.0 times upper limit of normal (ULN) OR calculated creatinine clearance ≥ 30 mL/min ...

5. Study of Nanoliposomal Irinotecan (Nal-IRI)-Containing Regimens in Patients With Previously Untreated, Metastatic Pancreatic Adenocarcinoma - Mayo Clinic

   Platelet count > 100,000 cells/μl;; Hemoglobin > 9 g/dL; transfusion is allowed, provided interval is ≥ 7 days prior to Screening. Adequate hepatic function ...

6. Corticosteroids + Bevacizumab vs. Corticosteroids + Placebo (BEST) for Radiation Injury After Treatment for Brain Metastases - Mayo Clinic

   Platelet Count ≥ 100,000/mm3; Hemoglobin ≥ 10 g/dL*; allowing transfusion or other intervention to achieve this minimum hemoglobin; BUN < 30 mg/dL; Creatinine ...

7. A Study to Evaluate the Safety and Tolerability of KTE-X19 in Adults with Relapsed/Refractory Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma - Mayo Clinic

   Platelet count ≥ 50 × 109/L;; Neutrophil count ≥ 0.5 × 109/L;; Hemoglobin ≥ 8 g/dL unless lower values are attributable to CLL. Adequate renal, hepatic ...

8. Treatment Of Antibody-Mediated Rejection (ABMR) With CarBel - Mayo Clinic

   Very low blood counts (hemoglobin, neutrophils, or platelets). 14. Positive for HIV, Hepatitis B, or Hepatitis C, unless Hepatitis C was successfully ...

9. Continued Access To PREVAIL (CAP2) - Mayo Clinic

   The subject has thrombocytopenia (defined as < 70,000 platelets/mm3) or anemia with hemoglobin concentration of < 10 g/dl (i.e., anemia as determined by the ...

10. Phase 3 Study of DCC-2618 vs Placebo in Advanced GIST Patients Who Have Been Treated With Prior Anticancer Therapies - Mayo Clinic

    Platelet count ≥5,000/μL;; Total bilirubin ≤.5 x the upper limit of normal (ULN);; Aspartate transaminase and alanine transaminase ≤ x ULN (≤x ULN in the ...